Video

John DeLuca, PhD

Publish date: June 13, 2018

At the 2018 CMSC Annual Meeting, Dr. DeLuca discusses the role of cognitive rehabilitation in MS.

 

Recommended Reading

Pregnancy may be ideal time to consider switching MS drugs
MDedge Neurology
Focus on preventing comorbidities in MS, physician urges
MDedge Neurology
Global MS trends: A chaotic picture with risk as the central theme
MDedge Neurology
Ocrelizumab’s Benefits on Confirmed Disability Improvement Persist in Open-Label Extension
MDedge Neurology
More Frequent Dosing of Interferon Beta-1a May Benefit Patients With MS With Breakthrough Disease
MDedge Neurology
Can Exercise Improve Vision in Children With MS?
MDedge Neurology
Compared With Interferon, Fingolimod Improves MRI Outcomes of Pediatric MS
MDedge Neurology
Cladribine Tablets Improve MRI Outcomes in Patients With Highly Active Relapsing-Remitting MS
MDedge Neurology
What Are Predictors of Mortality in Veterans With MS?
MDedge Neurology
Take precautions as cancer picture in MS remains hazy
MDedge Neurology

Related Articles